| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |